First Wave BioPharma Inc.

NASDAQ: FWBI · Real-Time Price · USD
2.96
0.13 (4.59%)
At close: May 16, 2024, 10:00 PM

First Wave BioPharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-18.06M -15.79M -14.63M -58.54M
Depreciation & Amortization
48.95K 29.27K 29.27K 542.25K
Stock-Based Compensation
631.55K 1.04M 769.12K 1.37M
Other Working Capital
n/a 2.26M -8.51M 15.69M
Other Non-Cash Items
n/a -8.74K 1.99M 3.46M
Deferred Income Tax
n/a 165.76K n/a 3.77M
Change in Working Capital
n/a 2.19M -10.5M 17.1M
Operating Cash Flow
-9.22M -12.38M -22.34M -32.29M
Capital Expenditures
n/a -500K n/a -10.32M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
88.17K -500 n/a -10.25K
Investing Cash Flow
88.17K -500K n/a -10.32M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-240.97K n/a n/a n/a
Other Financial Acitivies
4.28M 15.23M 15.74M 44.76M
Financial Cash Flow
5.58M 15.23M 15.74M 44.76M
Net Cash Flow
-3.55M 2.35M -6.86M 2.19M
Free Cash Flow
-9.22M -12.88M -22.34M -42.61M